Source: Fortune
Summary
Cigna’s chief data, digital, and AI officer, Katya Andresen, emphasized shifting from “how do I use AI?” to “how do I lead in an age of AI?” Cigna projects AI tools will save $200 million over three years by identifying chronic conditions early. The company also invested $100 million in AI to streamline clinical documentation. Andresen highlighted AI’s role in improving patient outcomes, such as encouraging the use of cheaper biosimilars over biologics. Cigna uses AI to analyze patient questions and improve communication, while also partnering with AI startups and large tech firms.
Our Reading
The numbers tell one story.
Cigna’s AI tools are projected to save $200 million by identifying chronic conditions early.
The company invested $100 million to use AI in clinical documentation and prescription processes.
AI helped increase biosimilar adoption, saving patients hundreds of millions.
The focus is on measurable outcomes, not just AI adoption.
Author: Evan Null
AI as a Strategic Lens
Cigna’s approach to AI is framed around leadership, not just technology. The company is not just deploying AI tools but redefining how they can shape healthcare outcomes. This shift from “how do I use AI?” to “how do I lead in an age of AI?” signals a broader strategic reorientation. It’s not about chasing the latest AI trends, but about embedding AI into the core of how the company operates and serves its customers.
Measurable Outcomes Over Hype
Cigna’s AI initiatives are tied to concrete financial and health outcomes. The $200 million savings projection and the 80% biosimilar adoption rate are not just PR numbers—they are results of targeted AI applications. These outcomes are critical in an industry where cost and efficiency are under constant pressure. The focus is on what AI can do, not just what it can be.
Compliance and Control in AI
Andresen emphasized that Cigna’s AI initiatives are built on a foundation of compliance and governance. The company has had controls in place for years, which is crucial in an industry where data privacy and accuracy are paramount. This approach suggests that Cigna is not just adopting AI but doing so with a level of caution and regulation that many other companies are still catching up to.
AI as a Conversational Tool
Cigna is moving toward a future where AI is more conversational and proactive. The company is investing in tools that can understand and respond to patient questions in a more natural way. This shift reflects a growing trend in healthcare, where AI is no longer just a back-office tool but a front-line assistant for both patients and providers.
Partnerships and Proprietary Data
Cigna is leveraging both its own data and partnerships with major AI players like Microsoft, OpenAI, and Anthropic. This dual approach allows the company to build tools that are both unique and powerful. By working with startups and large tech firms, Cigna is positioning itself to stay ahead in the AI race while maintaining control over its data and models.
